¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Silver syndrome"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • Taussig-Bing syndrome
    Ÿ¿ì½Ã±×-ºùÁõÈıº
  • tarsal tunnel syndrome
    ¹ß¸ñ±¼ÁõÈıº, Á·±Ù°üÁõÈıº
  • ulnar tunnel syndrome
    ÀÚ±¼ÁõÈıº, ô°ñ°üÁõÈıº
  • uncombable hair syndrome
    ¾ûÅ´ÅÐÁõÈıº
  • velocardiofacial syndrome
    ÀÔõÀå½ÉÀå¾ó±¼ÁõÈıº, ±¸°³½ÉÀå¾È¸éÁõÈıº
  • vanishing lung syndrome
    ¼Ò¸êÆóÁõÈıº, »ç¶óÁö´ÂÇãÆÄÁõÈıº
  • vanishing testes syndrome
    ¼Ò¸ê°íȯÁõÈıº
  • Wiskott-Aldrich syndrome
    ºñ½ºÄÚÆ®-¿Ãµå¸®Ä¡ÁõÈıº
  • withdrawal syndrome
    ±Ý´ÜÁõÈıº
  • Wolff-Parkinson-White syndrome
    ¿ùÇÁ-ÆÄŲ½¼-È­ÀÌÆ®ÁõÈıº
  • wasting syndrome
    ¼Ò¸ðÁõÈıº
  • Waterhouse-Friderichsen syndrome
    ¿öÅÍÇϿ콺-ÇÁ¸®µ¥¸¯¼¾ÁõÈıº
  • Werner¡¯s syndrome
    º£¸£³ÊÁõÈıº
  • Wernicke¡¯s syndrome
    º£¸£´ÏÄÉÁõÈıº
  • X-linked lymphoproliferative syndrome
    X¿¬°ü¸²ÇÁ±¸Áõ½ÄÁõÈıº
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • acute radiation syndrome
    ±Þ¼º¹æ»ç¼±ÁõÈıº(¡­Û¯ÞÒàÊñøý¦ÏØ)
  • adherence syndrome, Johnson
    ÁÔ½¼À¯ÂøÁõÈıº
  • adhesive syndrome
    À¯ÂøÁõÈıº
  • adrenosympathetic syndrome
    ºÎ½Å±³°¨½Å°æ(¼º) ÁõÈıº(¡­ÎßÊïãêÌèàõñøý¦ÏØ).
  • adult adrenogenital syndrome
    ¼ºÀÎ ºÎ½Å ¼º±â ÁõÈıº
  • adult respiratory distress syndrome
    ¼ºÀμº È£Èí°ï¶õÁõÈıº(à÷ìÑàõû¼ýåÍÝÑññøý¦ÏØ).
  • adult respiratory distress syndrome(ards)
    ¼ºÀμºÈ£Èí°ï¶õÁõÈıº(à÷ìÑàõû¼ýåÍÝÑññøý¦ÏØ)
  • advanced sleep phase syndrome
    ÀüÁø¼º ¼ö¸éÀ§»ó ÁõÈıº
  • aeroadaptation syndrome
    Ç×°ø¼øÀÀÁõÈıº(̰˭ËàËô̷̡˴).
  • afferent loop syndrome
    ¼öÀÔ°¢ÁõÈıº.
  • aids=£¾acquired immune deficiency syndrome
    ÈÄõ¼º¸é¿ª°áÇÌÁõÈıº(ý­ô¸àõØóæ¹ÌÀù¹ñøý¦ÏØ)
  • albrights syndrome
    ¾ËºÎ¶óÀÌÆ® ÁõÈıº(¡­ñøý¦ÏØ)
  • alports syndrome
    ¾ËÆ÷¿ÀÆ®ÁõÈıº
  • alports syndrome(disease)
    ¾ËÆ÷Æ® ÁõÈıº(º´)(¡­ñøý¦ÏØ)
  • alveolar hypoventilation syndrome
    ÆóÆ÷Àúȯ±âÁõÈıº.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • dresslers syndrome
    dresslerÁõÈıº
  • dresslers syndrome
    µå·¹½½·¯ ÁõÈıº(¡­ñøý¦ÏØ)
  • dry eye syndrome
    °Ç¼º¾ÈÁõÈıº
  • duane retraction syndrome
    µÎ¿£±Û ÀÌ»óÁõÈıº
  • dubin-johnson syndrome
    µàºó-Á¸½¼ ÁõÈıº(¡­ñøý¦ÏØ)
  • dumping syndrome
    ´ýÇÎ ÁõÈıº
  • dumping syndrome
    ´ýÇÎÁõÈıº(¡­ÁõÈıº).
  • dumping syndrome
    ´ýÇÎÁõÈıº(¡­ñøý¦ÏØ).
  • dumping syndrome
    ´ýÇÎÁõÈıº(¡­ñøý¦ÏØ).
  • dysconnection syndrome
    ºÐ¸®ÁõÈıº.
  • dysglandular syndrome
    ³»ºÐºñ¼±½ÇÁ¶ÁõÈıº(Ò®ÝÂù²àÍã÷ðàñøý¦ÏØ).
  • dyskinetic syndrome
    ¿îµ¿Àå¾ÖÁõÈıº.
  • dysplastic nevus syndrome
    ÀÌÇü¼º ¸ð¹Ý ÁõÈıº
  • dysuria-pyuria syndrome
    ¹è´¢Àå¾Ö-³ó´¢ ÁõÈıº
  • early postprandial postgastrectomy syndrome
    Á¶±â½ÄÈļº À§ÀýÁ¦ÈÄÁõÈıº.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 18
MRKH Syndrome Mayer-Rokitansky Kster-Hauser Syndrome
  = Mllerian Agenesis
NAME Syndrome Nevi, Atrial myxoma, Myxoid neurofibroma, Ephelides Syndrome
PICA Posterior Inferior Cerebellar Artery
  ; Obstruction½Ã¿¡ Wallenberg's Syndrome(= Lateral...
P-J syndrome Peutz-Jeghers syndrome
P-K syndrome Paterson-Kelly syndrome
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 18
DJS Dubin Johnson Syndrome
DNS Dysplastic Naevus Syndrome
EDS IV Ehlers-Danlos syndrome type IV
ESS Empty sella syndrome
EMS Eosinophilia Myalgia Syndrome
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Letterer-Siwe syndrome
    ·¹Å×·¯-½Ã¿þ ÁõÈıº
  • Libman Sachs syndrome
    ¸®ºê¸¸-ÀÛ½º ÁõÈıº
  • linear nevus sebaceous syndrome
    ¼±»ó ¸ð¹Ý ÇÇÁö¼± ÁõÈıº
  • lobotomy syndrome
    ³ú¿± Àý´Ü¼ú ÁõÈıº
  • lock pin ¼±´ÜÀº taperÇÏ°í µÎºÎ´Â ±¸»óÀ¸·Î µÇ¾î ÀÖ´Â Ä¡³»°ñ³» ¸Å½ÄüÀÇ ÀÏÁ¾.

    locked-in syndrome

    Æó¼â ÁõÈıº
  • long tract syndrome
    Àå°æ·Î ÁõÈıº
  • low output syndrome
    Àú ¹ÚÃâ·® ÁõÈıº
  • low salt syndrome
    Àú¿° ÁõÈıº
  • lower nephron syndrome
    ÇϺΠ³×ÇÁ·Ð ÁõÈıº
  • lupus erythematosus like syndrome
    È«¹Ý¼º ·çǪ½º¾ç ÁõÈıº
  • lupus-like syndrome
    ³¶Ã¢ ¾ç»óÀÇ ÁõÈıº
  • luxury perfusion syndrome
    ȣȭ °ü·ù ÁõÈıº
  • Lyell syndrome
    Lyell ÁõÈıº
  • malabsorption syndrome
    Èí¼öÀå¾Ö ÁõÈıº
    Á¤°ü¿¡¼­ÀÇ ¿µ¾ç¹° Èí¼öÀÇ Àå¾Ö¸¦ °¡Á®¿À´Â ÁúȯÀ» ÃѰýÇÏ´Â ¸íĪ. ¼³»ç, üÁß °¨¼Ò, ¿µ¾ç½ÇÁ¶¸¦ °¡Á®¿À´Â ¿øÀÎÀÌ µÇ´Â ÁúȯÀº Àå°ü ¼ö¼ú µÚ, Àå Áúȯ, ÃéÀå Áúȯ, °£´ãµµ Áúȯ, ¸²ÇÁÁ¾, ½ÉºÎÀü, ½É³¶¿°, ¾Æ´Ò·ÎÀ̵å½Ã½º, ¥â-Áö¹æ ´Ü¹é °á¼ÕÁõ, ½ºÇª·ç¿ì
  • maladaptation syndrome
    ÀûÀÀ Àå¾Ö ÁõÈıº
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
Maranon's syndrome <syndrome> A syndrome characterised by ovarian insufficiency, scoliosis, and flat-feet.
(05 Mar 2000)
paraneoplastic syndrome <oncology, syndrome> A collection of symptoms or clinical signs that are found in patients that have malignant disease. By definition, the signs and symptoms are not produced by a direct effect of a tumour or its metastasis nor due to direct invasion, compression, metastasis, infection, nutritional deficiency or treatment of the underlying neoplasm.
Paraneoplastic syndromes can arise from tumour produced biologically active polypeptides or proteins, autoimmunity or immune complex production and immune suppression, blockade of the normal effect of a hormone, the release of substances from tumour associated endothelium which are not normally released and finally unknown causes.
The best characterised paraneoplastic syndrome is the syndrome of inappropriate ADH.
(15 Dec 1997)
Marchiafava-Micheli syndrome An infrequent disorder with insidious onset (usually in the third or fourth decade) and chronic course, characterised by episodes of haemolytic anaemia, haemoglobinuria (chiefly at night), pallor, icterus or bronzing of the skin, a moderate degree of splenomegaly, and sometimes hepatomegaly; red blood cells are usually macrocytic and vary considerably in size, but there is no evidence of spherocytosis, erythrophagocytosis, or abnormal leukocytes. The disorder is a result of an abnormality of the red cell membrane which makes the red cell unusually sensitive to lysis by complement.
Synonym: Marchiafava-Micheli anaemia, Marchiafava-Micheli syndrome.
(05 Mar 2000)
Marcus Gunn syndrome <syndrome> An increase in the width of the eye lids during chewing, sometimes with a rhythmic elevation of the upper lid when the mouth is open and ptosis when the mouth is closed.
Synonym: Gunn phenomenon, Gunn's syndrome, jaw-winking phenomenon, jaw-working reflex, Marcus Gunn phenomenon, Marcus Gunn syndrome.
(05 Mar 2000)
Marfan's syndrome <syndrome> A hereditary condition of the connective tissue.
Symptoms and signs include tall lean body type, irregular or unsteady gait, long extremities (including fingers and toes), abnormal joint flexibility, flat feet, stooped shoulders, dislocation of the optic lens and aneurysms of the aorta. Affects 1 in 50,000 people. Probably a collagen fibril assembly disorder since it can be mimicked in mice by aminonitriles that interfere with crosslinking.
Inheritance: autosomal dominant.
(06 Oct 1997)
marfan syndrome <radiology> Connective-tissue disorder: autosomal dominant, 15% sporadic, cardiovascular system (probable cause of death in 93%), aortic aneurysm (mostly ascending), dilatation of aortic sinuses, aortic dissection, coarctation, musculoskeletal system, tall stature, long limbs, arachnodactyly, lax joints, scoliosis (60%) / kyphosis / pectus, eye, lens subluxation Cf: homocystinuria More info: Marfan syndrome
(12 Dec 1998)
Marie-Robinson syndrome <syndrome> Insomnia and mild melancholia associated with alimentary levulosuria.
(05 Mar 2000)
Marinesco-Garland syndrome <syndrome> A rare neurologic disorder characterised by cerebellolental degeneration with mental retardation; autosomal recessive inheritance.
Synonym: cataract-oligophrenia syndrome, Marinesco-Sjogren syndrome, Torsten Sjogren's syndrome.
(05 Mar 2000)
Marinesco-Sjogren syndrome <syndrome> A rare neurologic disorder characterised by cerebellolental degeneration with mental retardation; autosomal recessive inheritance.
Synonym: cataract-oligophrenia syndrome, Marinesco-Sjogren syndrome, Torsten Sjogren's syndrome.
(05 Mar 2000)
verner-morrison syndrome <radiology> WDHA syndrome, watery diarrhoea, hypokalaemia, achlorhydria, vasoactive intestinal peptide (VIP) secreted by, pancreatic isleT-cell tumour (VIPoma)
(12 Dec 1998)
Vernet's syndrome <syndrome> A syndrome characterised by paralysis of the motor components of the glossopharyngeal, vagus, and accessory cranial nerves as they lie in the posterior fossa; it is most commonly the result of head injury.
(05 Mar 2000)
Maroteaux-Lamy syndrome <biochemistry, syndrome> An error of mucopolysaccharide metabolism due to deficiency of the lysosomal enzyme arylsulphatase B.
It is characterised by excretion of dermatan sulfate in the urine, growth retardation, lumbar kyphosis, sternal protrusion, genu valgum, usually hepatosplenomegaly, and no mental retardation.
Onset occurs after two years of age.
Inheritance: autosomal recessive.
Synonym: polydystrophic dwarfism, mucopolysaccharidosis type VI.
(05 Mar 2000)
Marshall syndrome <syndrome> Syndrome of mid-face hypoplasia, cataract, sensorineural hearing loss, and hypohidrosis. It is disputed whether this syndrome is distinct from Stickler's syndrome.
(05 Mar 2000)
carotid artery occlusive syndrome <syndrome> Aortic arch syndrome, also referred to by many as vertebral-basilar artery disease, carotid artery occlusive syndrome and subclavian steal syndrome.
Characterised by a constellation of signs and symptoms which occur secondary to abnormalities in the major arteries which extend off of the aortic arch. These abnormalities are structural and most often secondary to the effects of atherosclerosis, blood clots, trauma or a congenital abnormality.
Symptoms of this condition include various neurologic symptoms, reduction in pulse and changes in blood pressure.
(27 Sep 1997)
carotid sinus syndrome <syndrome> Stimulation of a hyperactive carotid sinus, causing a marked fall in blood pressure due to vasodilation, cardiac slowing, or both; syncope with or without convulsions or A-V block may occur.
Synonym: Charcot-Weiss-Baker syndrome.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 18
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 18
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 18
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 18
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 18
ÅëÇÕ°Ë»ö ¿Ï·á